HRP931011A2 - Benzothiazepine and benzoxazepine derivatives - Google Patents

Benzothiazepine and benzoxazepine derivatives

Info

Publication number
HRP931011A2
HRP931011A2 HR07/907,413A HRP931011A HRP931011A2 HR P931011 A2 HRP931011 A2 HR P931011A2 HR P931011 A HRP931011 A HR P931011A HR P931011 A2 HRP931011 A2 HR P931011A2
Authority
HR
Croatia
Prior art keywords
benzothiazepine
benzoxazepine derivatives
benzoxazepine
derivatives
Prior art date
Application number
HR07/907,413A
Other languages
English (en)
Inventor
Arthur A Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP931011A2 publication Critical patent/HRP931011A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR07/907,413A 1992-07-01 1993-06-30 Benzothiazepine and benzoxazepine derivatives HRP931011A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90741392A 1992-07-01 1992-07-01

Publications (1)

Publication Number Publication Date
HRP931011A2 true HRP931011A2 (en) 1997-02-28

Family

ID=25424055

Family Applications (1)

Application Number Title Priority Date Filing Date
HR07/907,413A HRP931011A2 (en) 1992-07-01 1993-06-30 Benzothiazepine and benzoxazepine derivatives

Country Status (12)

Country Link
US (1) US5618808A (xx)
EP (1) EP0648213A1 (xx)
JP (1) JP2655754B2 (xx)
CN (1) CN1083485A (xx)
AU (1) AU4282993A (xx)
CA (1) CA2139417A1 (xx)
FI (1) FI933019A (xx)
HR (1) HRP931011A2 (xx)
HU (1) HUT68710A (xx)
IL (1) IL106123A0 (xx)
MX (1) MX9303966A (xx)
WO (1) WO1994001421A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420763D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
US6319915B1 (en) * 1999-08-27 2001-11-20 Pfizer Inc. Benzazepine derivatives as inhibitors of hyperproliferation diseases
KR20030082049A (ko) * 2002-04-16 2003-10-22 주식회사 효성 고투명성 폴리아미드 섬유의 제조방법
AU2006239929B2 (en) * 2005-04-22 2011-11-03 Alantos Pharmaceuticals Holding, Inc. Dipeptidyl peptidase-IV inhibitors
CN109071504B (zh) 2016-02-05 2022-03-08 戴纳立制药公司 受体相互作用蛋白激酶1的抑制剂
CN110383066B (zh) 2016-12-09 2023-03-31 戴纳立制药公司 化合物、组合物和方法
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CA2139417A1 (en) 1994-01-20
WO1994001421A1 (en) 1994-01-20
FI933019A0 (fi) 1993-06-30
US5618808A (en) 1997-04-08
HU9301903D0 (en) 1993-09-28
MX9303966A (es) 1994-02-28
IL106123A0 (en) 1993-10-20
AU4282993A (en) 1994-01-31
HUT68710A (en) 1995-07-28
EP0648213A1 (en) 1995-04-19
CN1083485A (zh) 1994-03-09
JPH07507808A (ja) 1995-08-31
FI933019A (fi) 1994-01-02
JP2655754B2 (ja) 1997-09-24

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
PL311736A1 (en) Derivatives of 1h-imidazoles
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
GB2231329B (en) Benzazepine and benzothiazepine derivatives
ZA939291B (en) Diazepine derivatives
HRP931011A2 (en) Benzothiazepine and benzoxazepine derivatives
HU9501693D0 (en) Benzazepinone derivatives
LTIP657A (en) Benzodiazepine derivatives
SG52154A1 (en) Isothiazole derivatives and their uses
ZA902150B (en) Benzazepine and benzothiazepine derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
GB9317692D0 (en) Benzodiazepine derivatives
PL307231A1 (en) Pyridoindolobenzodiazepines and their derivatives as antipsychotic agents
NZ248041A (en) Aminoalkyl- tetrahydrofuran derivatives and medicaments
EP0565961A3 (en) Ethyl-triazolyl derivatives
EP0486727A3 (en) Microbial reduction of benzazepine and benzothiazepine derivatives
ZA894315B (en) Benzazepine and benzothiazepine derivatives
IL115820A0 (en) Substituted tetracyclic oxazepine and thiazepine derivatives
GB9421887D0 (en) Benzodioxanylimidazoline and bensodioxanyllimidazole derivatives
IL130921A0 (en) Tetrahydroisoindole and hexahydroisoindole derivatives
IE901697L (en) Thiazepine derivatives
GB9300568D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives
GB9324403D0 (en) Benzodioxanylimidazoline and benzodioxanylimidazole derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
OBST Application withdrawn